abstract |
(57) [Summary]nThe present invention relates to a method for preventing human cancer, certain non-cancer hormone-dependent diseases and / or heart diseases based on administering hydroxymatairesinol to humans. The present invention also relates to a method of increasing the concentration of enterolactone or other metabolites of hydroxymatairesinol in human serum, based on administering hydroxymatairesinol to a human, whereby the cancer in humans is increased. And methods for effecting prevention of certain non-cancer hormone-dependent diseases. Furthermore, the present invention relates to pharmaceuticals, food additives and foods comprising hydroxymatairesinol. |